Microlife's Home Blood Pressure Monitors Proven Accurate Even for Critica...(t been clear if oscillometric devices wh...),Health

Date:10/2/2007

t been clear if oscillometric devices, which are used for home and ambulatory blood pressure monitoring, are accurate in such patients. Blood pressure measured at the time of dialysis may not accurately reflect the overall level of blood pressure in these patients, and home monitoring may prove to be very useful. Our research study demonstrated that the Microlife 3AC1-1PC digital home blood pressure monitor accurately measured blood pressure in patients with ESRD."

The patented algorithm used in the Microlife 3AC1-1PC is the same used in all of Microlife's upper arm monitors. This algorithm earned Microlife an A/A, the highest possible grade in accuracy, according to the British Hypertension Society's protocol as tested by unaffiliated researchers. Dr. Ken Kronhaus, M.D., renowned cardiologist and host of Good Day Health with Dr. Ken, says "Microlife's dedication to continued research and development of their blood pressure monitors make them my first choice when recommending a home monitor to my patients. I am confident that my patients are getting accurate results at home and this study proves it, even in very critical patients with End Stage Renal Disease, where measurement can be difficult."

Microlife is a global company and the world leader in the development and manufacturing of medical diagnostic equipment for home and institutional use. Blood pressure monitors, digital and infrared thermometers and peak flow meters are Microlife's core business. Microlife is a vertically integrated manufacturing company with a worldwide sales and distribution network. Microlife exports over 35 million medical devices each year from its ISO Certified (ISO9001 and ISO13485) factory in Shenzhen, China to all parts of the world. Each device utilizes leading edge technology for monitoring key health indicators. The Microlife family consists of more than 2,600 dedicated employees worldwide and is committed to continued research and development in medical devices that e
'/>"/>

SOURCE Microlife USA, Inc. Copyright©2007 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3
Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
8. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
9. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant